Key Dates

Related Announcements

None

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) is seeking input on the required resources and resulting opportunities in the development and implementation of Data and Management and Sharing (DMS) plans for cancer biology research. Review of this entire Request for Information (RFI) notice is encouraged to ensure a comprehensive response and to have a full understanding of how your response will be used.

Background

Basic cancer biology research generates valuable insight about the fundamental mechanisms of cancer initiation, progression, and response to therapy. Broad sharing of cancer biology research can result in novel hypotheses and discoveries, compounding the original impact of any individual investigation. To reinforce NIH's longstanding commitment to making the results and outputs of NIH-funded research available to the public through effective and efficient data management and data sharing practices, the National Institutes of Health (NIH) issued the Data Management and Sharing (DMS) Policy, effective in 2023. This policy requires all NIH-funded investigators to develop and implement a plan describing the management, preservation, and sharing of biomedical data. Under the DMS Policy, NIH requires investigators and institutions to develop and submit a plan for the management and sharing of research data and to comply with the approved DMS plan. The DMS plan should include information on data type, standards, preservation, access, reuse, and oversight. NCI would like to understand the required resources and resulting opportunities that cancer biology investigators face in the development and implementation of DMS plans. Further, NCI is interested in understanding the institutional support, training, and resources that cancer biology investigators have utilized, along with investigators’ considerations of the reuse of shared cancer biology data. 

Information Requested

NCI is soliciting feedback on the current experiences of investigators pursing projects that further our fundamental understanding of cancer biology in developing and implementing DMS plans including:

1. Career stage and role of contributors to DMS plans.
2. Resources needed for the development and implementation of NIH DMS plans.
3. Impact of shared data, including the reuse of cancer biology datasets and perceived reach of cancer biology datasets in compliance with the approved NIH DMS Plans .

How to Submit a Response

We welcome any feedback or comments from those involved in preparing NIH DMS plans for cancer biology research. We have provided suggested questions and multiple-choice answers via webform and welcome feedback or comments outside of these questions via email. All responses must be submitted through the Web-Form or emailed to [email protected] by August 9, 2024. 
Responses to this RFI are voluntary. Do not include any proprietary, classified, confidential, trade secret, or sensitive information in your response. The responses will be reviewed by NIH staff, and individual feedback will not be provided to any responder. The Government will use the information submitted in response to this RFI at its discretion. Any identifiers (e.g., names, institutions, e-mail addresses, etc.) will be removed when responses are compiled. The Government reserves the right to use only the processed, anonymized results on public NIH websites, in reports, in summaries of the state of the science, in any possible resultant solicitation(s), grant(s), or cooperative agreement(s), or in the development of future funding opportunity announcements.
This RFI is for information and planning purposes only and shall not be construed as a solicitation, grant, or cooperative agreement, or as an obligation on the part of the Federal Government, the NIH, or individual NIH Institutes and Centers to provide support for any ideas identified in response to it. The Government will not pay for the preparation of any information submitted or for the Government’s use of such information. No basis for claims against the U.S. Government shall arise as a result of a response to this RFI or from the Government’s use of such information.
The NCI looks forward to your input, and we hope that you will share this RFI document with your colleagues for their input.
 

Inquiries

Please direct all inquiries to:

Jourdan Ewoldt, Ph.D.
Division of Cancer Biology (DCB)
National Cancer Institute (NCI), 
Telephone: 240-276-6527
Email: [email protected]